Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Eidos Therapeutics Inc
EIDX

Buy EIDX Stock

EIDX
See EIDX stock price and Buy/Sell Eidos Therapeutics Inc with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.
EIDX

Eidos Therapeutics Inc (EIDX)

About Eidos Therapeutics Inc (EIDX)

BridgeBio is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients. The BridgeBio approach combines a traditional focus on drug development with a unique corporate model, allowing rapid translation of early stage science into medicines that treat disease at its source.
Market Cap
$4.75B
1 Year High
$132.54
Volume
1 Year Low
$28.39
Price to Earnings Ratio
Open
Dividend Rate
High
Dividend Yield
Low

Community

People who own or watch EIDX stock

EIDX Stock News

EIDX stock rating

What analysts recommend for EIDX stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
1.3

EIDX price target

What analysts think EIDX will be worth
Low $0
High $132.54
Current $0
Target $38.29

Events

List of events that could affect EIDX stock.
29Oct

Earnings data Q3 2020

24Feb

Earnings data Q4 2020

EIDX earnings

The value each share was expected to gain vs. the value that each share actually gained
0
-0.27
-0.55
-0.82
Q4 2020
Q1 2021
Q2 2021
Q3 2021

Expected EPS
Q3 2021
-$0.82
Actual EPS
Q3 2021

Buy EIDX Stock

EIDX
See EIDX stock price and Buy/Sell Eidos Therapeutics Inc with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.

Community

People who own or watch EIDX stock
  • sachimoe avatar
  • widlorlissaint avatar
  • marcusg avatar
  • juliamancuso avatar
  • ddohrmann avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency trading is provided by Apex Crypto LLC (“Apex Crypto”). Apex Crypto is not a registered broker-dealer or FINRA member and is not affiliated with Public Holdings or any of its subsidiaries. Cryptocurrencies are not securities and your cryptocurrency holdings are not FDIC or SIPC insured. Crypto trading involves a substantial risk of loss as there is significant volatility in the price of cryptocurrencies.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.